← Back to Patent Explorer
US4035566A Expired / Lapsed US ⏱️ 0.0 years remaining

N-trifluoroacetyladriamycin-14-alkanoates and therapeutic compositions containing same

Assignee: Dana Farber Cancer Institute Inc
•
Filing: 1975-09-25
•
Granted: 1977-07-12
•
Expires: 1995-09-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Esters of C4-C10 saturated fatty acids with N-trifluoroacetyladriamycin are novel compounds. These compounds have the following structure: <IMAGE> in which A is alkanoate having from 4 to 10 carbon atoms. Therapeutic compositions containing these compounds or the acetate or propionate of N-trifluoroacetyladriamycin are more effective than adriamycin in antitumor activity against murine P 388 and L 1210 leukemias and Ridgway osteogenic sarcoma in mice and at the same time significantly less toxic than adriamycin.

Inventors

  • 👤 Mervyn Israel
  • 👤 Edward J. Modest

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 21:41
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/20; C07H15/24; C07H15/252

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 16 words
N-trifluoroacetyladriamycin-14-alkanoates in which the alkanoate portion of the molecule contains from 4 to 10 carbon atoms.
Claim 2
Dependent Claim 16 words
N-trifluoroacetyladriamycin-14-alkanoates in which the alkanoate portion of the molecule contains from 4 to 10 carbon atoms.
Claim 3
Dependent Claim 12 words
The compound claimed in claim 1 in which the alkanoate is pentanoate.
Claim 4
Dependent Claim 12 words
The compound claimed in claim 1 in which the alkanoate is valerate.
Claim 5
Dependent Claim 12 words
The compound claimed in claim 1 in which the alkanoate is butanoate.
Claim 6
Dependent Claim 12 words
The compound claimed in claim 1 in which the alkanoate is isobutyrate.
Claim 7
Dependent Claim 12 words
The compound claimed in claim 1 in which the alkanoate is hexanoate.
Claim 8
Dependent Claim 12 words
The compound claimed in claim 1 in which the alkanoate is caproate.
Claim 9
Dependent Claim 12 words
The compound claimed in claim 1 in which the alkanoate is octanoate.
Claim 10
Dependent Claim 12 words
The compound claimed in claim 1 in which the alkanoate is caprylate.

References Cited (Backward Citations)

US3803124A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-07-11 1981-01-10 1981-07-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-07-11 1985-01-10 1985-07-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-07-11 1989-01-10 1989-07-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag